Humana Inc. to Present at TD Cowen's 44th Annual Health Care Conference
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation t...
Exit Now! 3 S&P 500 Stocks to Sell in February 2024
The S&P 500 is riding a hot streak having recently closed above 5,000 for the first time ever, marking a new all-time high for the benchmark stock market index. So far this year, the S&P 500, which...
Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm empl...
Humana Becomes Oversold
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two importa...
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Health insurance carrier Humana Inc. NYSE: HUM reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also slashe...
Buy the Dip! 3 Beaten-Down Stocks Poised for a Comeback.
The stock market might be at an all-time high, but that doesn't mean there aren't opportunities available to investors who want to buy low in the hopes of eventually selling high. In fact, one coul...
Top 4 Health Care Stocks That May Explode This Month - Mesoblast (NASDAQ:MESO), Humana (NYSE:HUM)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Why Humana Stock Dropped Today
Humana announced a surprise quarterly loss on higher medical cost trends to end 2023. Management also issued disappointing forward earnings guidance.
Steve Weiss sells Humana and UnitedHealth, says stocks are 'just not working'
Steve Weiss, Short Hills Capital Partners founder and managing partner, joins 'Halftime Report' to share his latest healthcare trades.
Humana (HUM) Q4 Earnings Miss on Higher Costs, '25 Target Pulled
Humana (HUM) expects 2024 revenues to increase to around $113 billion.
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
The medical cost increases reflect an increasing number of older adults returning to hospitals to undergo procedures they had delayed during the pandemic.
Compared to Estimates, Humana (HUM) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compa...
Humana issues 2024 profit warning amid rising costs; shares tumble
Humana (NYSE:HUM) shares tumbled more than 10% in early trade as the Kentucky-based health insurance firm warned its 2024 profits are expected to be impacted by higher costs associated with its Med...
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
Humana (HUM) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $1.62 per share a year ago.
Humana Dives On Huge 2024 Earnings Warning
The health insurer says 2024 earnings will be barely half of estimates due to higher Medicare Advantage costs.
Related Companies